Satsuma Technology Plc
('Satsuma' or the 'Company')
General Meeting Results - Proposed Return of Capital and Delisting
Introduction:
Satsuma LSE:SATS announces that at the General Meeting held earlier today the Special Resolutions to return substantially all of the Company's capital and to seek the cancellation of the Company's listing on the Equity Shares (Commercial Companies) category of the Official List of the FCA (Listing) were duly passed by shareholders. Accordingly, the Board has approved immediate action to prepare to close all the Company's trading activities and to sell the Company's Bitcoin.
General Meeting Voting:
Resolution Votes cast in favour Votes cast against | Number % Number % | To return substantially all the Company's capital 7,869,182,042 90.63% 813,703,719 9.37% | To cancel the Company's Listing 7,865,974,880 90.59% 816,694,745 9.41% |
Timetable:
The expected timetable for the Proposed Return of Capital is set out in the circular concerning the proposed Return of Capital (posted by the Company on 24th June 2026) ("Circular").
The Record Time for entitlement to B Shares is 6 p.m. on 3rd August 2026. Warrant holders have until such time to exercise Warrants in order for the resultant issued Ordinary Shares to participate in the Return of Capital.
UK Court Process:
Once the total number of Ordinary Shares entitled to B Shares is determined, an application will be made to the UK High Court to confirm the Return of Capital.
The expected date for a Court hearing in respect of directions is 13th August 2026 and the expected date for the Court hearing to confirm the Return of Capital is 8th September 2026. On this timetable cancellation of the Company's listing is expected to be on 14th September 2026 with despatch of payments and CREST transfers being made by 28th September 2026.
Enquiries:
Satsuma Technology Plc - [email protected]
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ROMEALXEAAFKEFA